Drug
Beclomethasone Dipropionate Formoterol
Beclomethasone Dipropionate Formoterol: highest development phase Phase 3, developed by Chiesi Farmaceutici. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Chiesi Farmaceutici
Trials
| Drug | Phase | Indication |
|---|---|---|
| Beclomethasone Dipropionate/Formoterol Fumarate NCT05292586 | Phase 3 | Asthma |
| Beclomethasone Dipropionate - Formoterol NCT01245569 | Phase 3 | Chronic Obstructive Pulmonary Disease |
Latest
No recent events.
Follow Beclomethasone Dipropionate Formoterol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.